top of page
WhatsApp Image 2026-04-02 at 11.46.53.jpeg

Our Services

Discovera S.r.l. provides integrated computational drug discovery services designed to support pharmaceutical and biotech research programs from early concept to lead optimization. The company offers advanced in-silico solutions that enhance target evaluation, compound design, and candidate selection, helping partners accelerate development timelines and improve decision-making through data-driven methodologies.

Drug Repurposing 

Discovera computationally screens approved and clinical-stage compounds against your disease target using AI-driven virtual screening, molecular dynamics, and polypharmacology analysis.

Identify repurposing candidates with predicted binding affinity, selectivity profiles, and safety flags.

Variants Analysis

Our population-specific analysis framework  predicts how genetic variants reshape protein structure, dynamics, and drug-target interactions across human populations. It provides the mechanistic foundation for anticipating inter-individual variability in drug efficacy and safety.

SB-CADD

Discovera provides structure-based CADD consulting to resolve mechanistic uncertainty before experimental commitment. Compounds and targets are evaluated through rigorous structural modeling and comparative interaction analysis, translating findings into clear conclusions.​

+39 3462329113

© 2024 by Discovera. All rights reserved

bottom of page